Mendeley supplemental table II. Summary of medication exposure for subjects with moderate-to-severe atopic dermatitis

Published: 23 September 2021| Version 1 | DOI: 10.17632/tbh86d3z8r.1
Contributor:

Description

Mendeley supplemental table II. for "The risk of COVID-19 infection in patients with atopic dermatitis - a retrospective cohort study"

Files

Categories

Atopic Dermatitis

License